Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease

References

• PaolettiMCamiciottoliGMeoniEExplorative data analysis techniques and unsupervised clustering methods to support clinical assessment of chronic obstructive pulmonary disease (COPD) phenotypesJ Biomed Inform20094261013102119501190
   PubMed Web of Science ®Google Scholar
• CamiciottoliGBigazziFPaolettiMCestelliLLavoriniFPistolesiMPulmonary function and sputum characteristics predict computed tomography phenotype and severity of COPDEur Respir J201342362663523258785
   PubMed Web of Science ®Google Scholar
• BurgelPRPaillasseurJLRocheNIdentification of clinical phenotypes using cluster analyses in COPD patients with multiple comorbiditiesBiomed Res Int201442013424683548
   PubMed Web of Science ®Google Scholar
• WeatherallMTraversJShirtcliffePMDistinct clinical phenotypes of airways disease defined by cluster analysisEur Respir J200934481281819357143
   PubMed Web of Science ®Google Scholar
• MarshSETraversJWeatherallMProportional classifications of COPD phenotypesThorax200863976176718728201
   PubMed Web of Science ®Google Scholar
• AgustíAEdwardsLDRennardSIEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotypePLoS One201275e3748322624038
   PubMed Web of Science ®Google Scholar
• AgustíAGNogueraASauledaJSalaEPonsJBusquetsXSystemic effects of chronic obstructive pulmonary diseaseEur Respir J200321234736012608452
   PubMed Web of Science ®Google Scholar
• GanWQManSFSenthilselvanASinDDAssociation between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysisThorax200459757458015223864
   PubMed Web of Science ®Google Scholar
• MacNeeWPathogenesis of chronic obstructive pulmonary diseaseProc Am Thorac Soc20052425826616267346
   PubMedGoogle Scholar
• SabitRBoltonCEEdwardsPHArterial stiffness and osteoporosis in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2007175121259126517363772
   PubMed Web of Science ®Google Scholar
• MaclayJDMcAllisterDAMillsNLVascular Dysfunction in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2009180651352019542477
   PubMed Web of Science ®Google Scholar
• ScholsAMBroekhuizenRWeling-ScheepersCAWoutersEFBody composition and mortality in chronic obstructive pulmonary diseaseAm J Clin Nutr2005821535916002800
   PubMed Web of Science ®Google Scholar
• Garcia-AymerichJLangePBenetMSchnohrPAntóJMRegular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort studyAm J Respir Crit Care Med2007175545846317158282
   PubMed Web of Science ®Google Scholar
• ManninoDMHiguchiKYuTCEconomic burden of COPD in the presence of comorbiditiesChest2015148113815025675282
   PubMed Web of Science ®Google Scholar
• GershonASMecredyGCGuanJVictorJCGoldsteinRToTQuantifying comorbidity in individuals with COPD: a population studyEur Respir J2015451515925142481
   PubMed Web of Science ®Google Scholar
• WackerMEJörresRASchulzHfor COSYCONET-consortiumDirect and indirect costs of COPD and its comorbidities: results from the German COSYCONET studyRespir Med2016111394626725462
   PubMed Web of Science ®Google Scholar
• TsiligianniIGKosmasEVan der MolenTTzanakisNManaging comorbidity in COPD: a difficult taskCurr Drug Targets201314215817623256716
   PubMed Web of Science ®Google Scholar
• AnecchinoCRossiEFanizzaCDe RosaMTognoniGRomeroMWorking Group ARNO projectPrevalence of chronic obstructive pulmonary disease and pattern of comorbidities in a general populationInt J Chron Obstruct Pulmon Dis20072456757418268930
   PubMedGoogle Scholar
• SodeBFDahlMNordestgaardBGMyocardial infarction and other co-morbidities in patients with chronic obstructive pulmonary disease: a Danish Nationwide Study of 7.4 million individualsEur Heart J201132192365237521875856
   PubMed Web of Science ®Google Scholar
• FearyJRRodriguesLCSmithCJHubbardRBGibsonJEPrevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary careThorax2010651195696220871122
   PubMed Web of Science ®Google Scholar
• Dal NegroRWBonadimanLTurcoPPrevalence of different comorbidities in COPD patients by gender and GOLD stageMultidiscip Respir Med20151012426246895
   PubMedGoogle Scholar
• MahboubBAlzaabiAIqbalMNComorbidities associated with COPD in the Middle East and North Africa region: association with severity and exacerbationsInt J Chron Obstruct Pulmon Dis20161127328026917957
   PubMed Web of Science ®Google Scholar
• PellegrinoRViegiGBrusascoVInterpretative strategies for lung function testsEur Respir J200526594896816264058
   PubMed Web of Science ®Google Scholar
• WatzHWaschkiBKirstenAThe metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivityChest200913641039104619542257
   PubMed Web of Science ®Google Scholar
• PoulainMDoucetMDrapeauVMetabolic and inflammatory profile in obese patients with chronic obstructive pulmonary diseaseChron Respir Dis200851354118303100
   PubMedGoogle Scholar
• SongDFangGGreenbergHLiuSFChronic intermittent hypoxia exposure-induced atherosclerosis: a brief reviewImmunol Res2015631–312113026407987
   PubMed Web of Science ®Google Scholar
• BernardoIBozinovskiSVlahosRTargeting oxidant dependent mechanisms for the treatment of COPD and its comorbiditiesPharmacol Ther2015155607926297673
   PubMed Web of Science ®Google Scholar
• OkurHKPelinZYukselMYosunkayaSLipid peroxidation and paraoxonase activity in nocturnal cyclic and sustained intermittent hypoxiaSleep Breath201317136537122528954
   PubMed Web of Science ®Google Scholar
• McNicholasWVerbraeckenJMarinJMSleep disorders in COPD: the forgotten dimensionEur Respir Rev20132212936537523997063
   PubMedGoogle Scholar
• JebouckABoonenSDecramerMJanssensWCOPD, bone metabolism and osteoporosisChest2011139364865721362651
   PubMed Web of Science ®Google Scholar
• LindBFengYThe association of low bone mineral density with systemic inflammation in clinically stable COPDEndocrine201242119019522198912
   PubMed Web of Science ®Google Scholar
• KiyokawaHMuroSOgumaTImpact of COPD exacerbations on osteoporosis assessed by chest CT scanCOPD20129323524222360380
   PubMedGoogle Scholar
• MineoTCAmbrogiVMineoDFabbriAFabbriniEMassoudRBone mineral density improvement after lung volume reduction surgery for severe emphysemaChest200512761960196615947308
   PubMed Web of Science ®Google Scholar
• ManninoDMThornDSwensenAHolguinFPrevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPDEur Respir J200832496296918579551
   PubMed Web of Science ®Google Scholar
• JohnstonAKManninoDMHaganGWDavisKJKiriVARelationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohortThorax200863759960518245145
   PubMed Web of Science ®Google Scholar
• MethvinJNManninoDMCaseyBRCOPD prevalence in Southeastern Kentucky: the burden of lung disease studyChest2009135110210718689574
   PubMed Web of Science ®Google Scholar
• VanfleterenLESpruitMAGroenenMClusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2013187772873523392440
   PubMed Web of Science ®Google Scholar
• CelliBRRecommendation for the early diagnosis of COPD: The AIMAR viewMultidiscip Respir Med2015101625729573
   PubMedGoogle Scholar
• WelteTVogelmeierCPapiACOPD: early diagnosis and treatment to slow disease progressionInt J Clin Pract201569333634925363328
   PubMed Web of Science ®Google Scholar
• BrownJPMartinezCHChronic obstructive pulmonary disease comorbiditiesCurr Opin Pulm Med201622211311826814720
   PubMed Web of Science ®Google Scholar